Stay updated on Primary Oral Insulin Immunotherapy Clinical Trial
Sign up to get notified when there's something new on the Primary Oral Insulin Immunotherapy Clinical Trial page.

Latest updates to the Primary Oral Insulin Immunotherapy Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA minor site revision was implemented (v3.3.2) replacing the previous revision (v3.3.1); there are no changes to study content, eligibility criteria, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedA new publication entry, 'Efficacy of once-daily, high-dose, oral insulin immunotherapy in children genetically at risk for type 1 diabetes (POInT): a European, randomised, placebo-controlled, primary prevention trial', was added to Publications. The Publications description was updated from 'These publications come from PubMed...' to 'These publications are automatically filled in from PubMed...'.SummaryDifference0.2%

- Check29 days agoChange DetectedRemoval of the temporary government-funding notice previously displayed on the page; this affects only operating-status messaging and does not alter study details, eligibility criteria, or contact information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check43 days agoChange DetectedThe Study Details page content appears unchanged between versions; the main sections (brief summary, inclusion criteria, design, outcomes, and locations) remain the same.SummaryDifference0.4%

- Check72 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference3%

- Check79 days agoChange DetectedAdds Revision: v3.1.0 and removes several drug-safety related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) alongside a prior Revision: v3.0.2.SummaryDifference0.4%

Stay in the know with updates to Primary Oral Insulin Immunotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Primary Oral Insulin Immunotherapy Clinical Trial page.